5311 - 5320 of 7939 Results
Title
Year
-
RESTRICTEDTitle: Immune system responses in Parkinson's disease: Early and dynamicJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 364End Page: 383Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14290Best OA location URL: https://europepmc.org/articles/pmc6391192?pdf=renderCitation Count: 107
- Regional gray matter changes and age predict individual treatment response in Parkinson's disease2018OPENTitle: Regional gray matter changes and age predict individual treatment response in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 21Issue #:Start Page: 101636End Page: 101636Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.101636Best OA location URL: https://doi.org/10.1016/j.nicl.2018.101636Citation Count: 25
-
RESTRICTEDTitle: Self-reported physical activity levels and clinical progression in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 61Issue #:Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.006Citation Count: 64
-
OPENTitle: Non-motor predictors of freezing of gait in Parkinson’s diseaseJournal Name: Gait & PosturePublisher: Elsevier BVVol: 68Issue #:Start Page: 311End Page: 316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.12.009Best OA location URL: https://europepmc.org/articles/pmc6773271?pdf=renderCitation Count: 44
- Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB2018OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 51Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 68
- Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease2018OPENTitle: Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington diseaseJournal Name: BMC Medical Informatics and Decision MakingPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12911-018-0714-7Best OA location URL: https://bmcmedinformdecismak.biomedcentral.com/track/pdf/10.1186/s12911-018-0714-7Citation Count: 32
-
OPENTitle: Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the BrainJournal Name: Molecular Therapy - Methods & Clinical DevelopmentPublisher: Elsevier BVVol: 11Issue #:Start Page: 29End Page: 39Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtm.2018.08.008Best OA location URL: http://www.cell.com/article/S2329050118300895/pdfCitation Count: 16
- The atypical RhoGTPase RhoE/Rnd3 is a key molecule to acquire a neuroprotective phenotype in microglia2018OPENTitle: The atypical RhoGTPase RhoE/Rnd3 is a key molecule to acquire a neuroprotective phenotype in microgliaJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1386-zBest OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1386-zCitation Count: 14
- CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies2018OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00620Citation Count: 37
- Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons2018OPENTitle: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine NeuronsJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 103Issue #: 6Start Page: 874End Page: 892Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018Best OA location URL: http://www.cell.com/article/S0002929718303707/pdfCitation Count: 34